Oral Presentation

Re-analysis of the CSM-PROTECT Multicentre Randomized Controlled Trial Reveals a Global Treatment Benefit of Riluzole in Patients Undergoing Surgery for Degenerative Cervical Myelopathy

Presenting Author(s)

• 

  Michael G. Fehlings, MD, PhD

  Neurosurgeon & Professor of Neurosurgery
  University of Toronto
  Toronto, ON, CA

Co-Author(s)

• CI

  CSM-Protect Investigators